News Headlines Article

UCLA study yields the key to effective personalized medicine

For decades, doctors and scientists have predicted that personalized medicine — tailoring drug doses and combinations to people’s specific diseases and body chemistry — would be the future of health care.

A team of UCLA bioengineers and surgeons has taken a major step toward that reality.

The researchers, from the UCLA schools of dentistry, engineering and medicine, developed a revolutionary technology platform called phenotypic personalized medicine, or PPM, which can accurately identify a person’s optimal drug and dose combinations throughout an entire course of treatment. Their research is the April 6 cover article of the peer-reviewed journal Science Translational Medicine, a publication of the American Association for the Advancement of Science.